CONTRAST-MEDIUM RECALLS INTERLEUKIN-2 TOXICITY

被引:22
作者
OLDHAM, RK [1 ]
BROGLEY, J [1 ]
BRAUD, E [1 ]
机构
[1] SPRINGFIELD CLIN,SPRINGFIELD,IL
关键词
D O I
10.1200/JCO.1990.8.5.942
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:942 / 943
页数:2
相关论文
共 6 条
[1]  
LOTZOVA E, 1988, NAT IMMUN CELL GROW, V7, P170
[2]   ACTIVATION AND EXPANSION OF TUMOR-DERIVED ACTIVATED CELLS FOR THERAPEUTIC USE [J].
MALECKAR, JR ;
FRIDDELL, CS ;
SFERRUZZA, A ;
THURMAN, GB ;
LEWKO, WM ;
WEST, WH ;
OLDHAM, RK ;
YANNELLI, JR .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (21) :1655-1660
[3]   A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].
ROSENBERG, SA ;
LOTZE, MT ;
MUUL, LM ;
CHANG, AE ;
AVIS, FP ;
LEITMAN, S ;
LINEHAN, WM ;
ROBERTSON, CN ;
LEE, RE ;
RUBIN, JT ;
SEIPP, CA ;
SIMPSON, CG ;
WHITE, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897
[4]   COMBINATION THERAPY WITH INTERLEUKIN-2 AND ALPHA-INTERFERON FOR THE TREATMENT OF PATIENTS WITH ADVANCED CANCER [J].
ROSENBERG, SA ;
LOTZE, MT ;
YANG, JC ;
LINEHAN, WM ;
SEIPP, C ;
CALABRO, S ;
KARP, SE ;
SHERRY, RM ;
STEINBERG, S ;
WHITE, DE .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) :1863-1874
[5]   USE OF TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN THE IMMUNOTHERAPY OF PATIENTS WITH METASTATIC MELANOMA - A PRELIMINARY-REPORT [J].
ROSENBERG, SA ;
PACKARD, BS ;
AEBERSOLD, PM ;
SOLOMON, D ;
TOPALIAN, SL ;
TOY, ST ;
SIMON, P ;
LOTZE, MT ;
YANG, JC ;
SEIPP, CA ;
SIMPSON, C ;
CARTER, C ;
BOCK, S ;
SCHWARTZENTRUBER, D ;
WEI, JP ;
WHITE, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (25) :1676-1680
[6]   CONSTANT-INFUSION RECOMBINANT INTERLEUKIN-2 IN ADOPTIVE IMMUNOTHERAPY OF ADVANCED CANCER [J].
WEST, WH ;
TAUER, KW ;
YANNELLI, JR ;
MARSHALL, GD ;
ORR, DW ;
THURMAN, GB ;
OLDHAM, RK .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :898-905